Prosjekter finansiert av KLINBEFORSK – Program for klinisk behandlingsforskning

Prosjekter finansiert av KLINBEFORSK


Prosjekter med finansiering etter utlysning av programmidler i 2017:

ProsjektSøkerinstitusjon /
prosjektleder
Tildeling
(mill. kroner)
BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial)Oslo universitetssykehus HF/
Dan Atar
20.00
Improved prediction of outcome by global strain and mechanical dispersion in patients with myocardial infarction, heart failure and primary prophylactic internal defibrillator.Oslo universitetssykehus HF/
Thor Edvardsen
15.49
Establishment of Molecular profiling for Individual clinical routine Treatment decisions in Early Breast Cancer (EMIT) – clinical trialsOslo universitetssykehus HF/
Bjørn Naume
17.57
BackToBasicOslo universitetssykehus HF/
John-Anker Zwart
13.84
Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing – INSTARSt. Olav’s hospital HF/
Henrik Døllner
19.32
Immunotherapy for Hematological Malignancies – A Path to CureSt. Olav’s hospital HF/
Henrik Hjorth-Hansen
12.43
Sphenopalatine ganglion block in chronic migraine (MIBLOCK)St. Olav’s hospital HF/
Anders Mattias Linde
18.72
Changing the specialist mental health careHelse Bergen HF/
Gerd Kvale
19.97

Prosjekter med finansiering etter utlysning av programmidler i 2016:

ProsjektSøkerinstitusjon /
prosjektleder
Tildeling
(mill. kroner)
Randomized autologous hematopoietic stem cell transplantation vs. Alemtuzumab for patients with relapsing remitting Multiple Sclerosis (RAM-MS)Helse Bergen HF /
Lars Bø
19.97
A Phase 1b/2 clinical trial with Axl kinase inhibitor BGB324 in combination with Dabrafenib/Trametinib or Pembrolizumab in metastatic melanoma: Identification of predictive markers of responseHelse Bergen HF /
Oddbjørn Straume
17.57
Acetylsalisylic acid as secondary prevention in colorectal cancer (ASAC Trial)Oslo universitetssykehus HF /
Bjørn Atle Bjørnbeth
13.84
The Norwegian Antibiotics for Pneumonia in Children (NAPiC) studyOslo universitetssykehus HF /
Håvard Ove Skjerven
19.32
A Norwegian multicentre trial assessing the effectiveness of tailoring infliximab treatment by therapeutic drug monitoring, the NOR-DRUM studyDiakonhjemmet Sykehus /
Espen A. Haavardsholm
12.43
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA-2): A randomized, placebo-controlled, multicenter TrialAkershus universitetssykehus HF /
Torbjørn Omland
20.00
Tenecteplase in wake-up ischaemic stroke trial – TWISTUniversitetssykehuset Nord-Norge HF /
Ellisiv B. Mathiesen
15.49